Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 25226226100
ResearcherID: M-2015-2013
Loop profile: 1035071

Countries

Italy

Activities

Collapse all

Employment (3)

University of Parma: Parma, IT

2013-01-01 to present | Post-DOC Fellow (Medicine and Surgery)
Employment
Source: Self-asserted source
Paola Storti

The University of Texas MD Anderson Cancer Center: Houston, Texas, US

2012-03-13 to 2012-10-12 | Visiting PhD Student (Genomic Medicine)
Employment
Source: Self-asserted source
Paola Storti

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2010-02-01 to 2012-01-31 | Research fellow (Clinical and Experimental Medicine)
Employment
Source: Self-asserted source
Paola Storti

Education and qualifications (4)

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2013-04-01 to 2014-01-15 | Hematopoietic stem cells and Regenerative medicine, Master (Clinic and Experimental Medicine)
Education
Source: Self-asserted source
Paola Storti

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2009-01-01 to 2013-03-19 | Molecular Biology and Pathology, PhD (Experimental Medicine)
Education
Source: Self-asserted source
Paola Storti

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2004-10-01 to 2007-09-24 | Biotechnology for Health, MS (Medicine and Surgery)
Education
Source: Self-asserted source
Paola Storti

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2001-10-01 to 2005-02-21 | Biotechnology, BS (Medicine and Surgery)
Education
Source: Self-asserted source
Paola Storti

Works (48)

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

bioRxiv
2023 | Other
DOI: 10.1101/2023.02.22.529457
EID:

2-s2.0-85152398140

Part of ISSN: 26928205
Contributors: Thongon, N.; Ma, F.; Lockyer, P.; Baran, N.; Liu, J.; Jackson, C.; Rose, A.; Wildeman, B.; Marchesini, M.; Marchica, V. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

The impact of CD56 expression in smoldering myeloma patients on early progression

Hematological Oncology
2023 | Journal article
DOI: 10.1002/hon.3104
EID:

2-s2.0-85143383038

Part of ISSN: 10991069 02780232
Contributors: Notarfranchi, L.; Segreto, R.; Vescovini, R.; Dalla Palma, A.B.; Marchica, V.; Burroughs-Garcia, J.; Toscani, D.; Todaro, G.; Raimondi, V.; Iannozzi, N.T. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

CD38 expression by plasma cells In extramedullary multiple myeloma.

Haematologica
2023-11-09 | Journal article
DOI: 10.3324/haematol.2023.284169
PMID: 37941401
Contributors: Notarfranchi L; Accardi F; Mancini C; Martella E; Bonomini S; Segreto R; Vescovini R; Palma ABD; Sammarelli G; Todaro G et al.
Source: Self-asserted source
Paola Storti

Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma.

Haematologica
2023-08-24 | Journal article
DOI: 10.3324/haematol.2023.283200
PMID: 37608776
Contributors: Garcia JB; Storti P; Iannozzi NT; Marchica V; Agnelli L; Toscani D; Franceschi V; Todaro G; Sammarelli G; Notarfranchi L et al.
Source: Self-asserted source
Paola Storti

Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response

OncoImmunology
2022 | Journal article
DOI: 10.1080/2162402X.2022.2120275
EID:

2-s2.0-85137931757

Part of ISSN: 2162402X 21624011
Contributors: Storti, P.; Marchica, V.; Vescovini, R.; Franceschi, V.; Russo, L.; Notarfranchi, L.; Raimondi, V.; Toscani, D.; Burroughs Garcia, J.; Costa, F. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

IMPACT OF OMICRON VARIANT ON THE RESPONSE TO SARS-COV-2 mRNA VACCINATION IN MULTIPLE MYELOMA

medRxiv
2022 | Other
DOI: 10.1101/2022.02.25.22271501
EID:

2-s2.0-85126339578
Contributors: Storti, P.; Marchica, V.; Vescovini, R.; Franceschi, V.; Russo, L.; Raimondi, V.; Toscani, D.; Garcia, J.B.; Costa, F.; Palma, B.D. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone disease

Frontiers in Oncology
2022 | Journal article
DOI: 10.3389/fonc.2022.1015402
EID:

2-s2.0-85140794095

Part of ISSN: 2234943X
Contributors: Raimondi, V.; Toscani, D.; Marchica, V.; Burroughs-Garcia, J.; Storti, P.; Giuliani, N.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma

International Journal of Molecular Sciences
2022-12-07 | Journal article
DOI: 10.3390/ijms232415448
Contributors: Nicolas Thomas Iannozzi; Valentina Marchica; Denise Toscani; Jessica Burroughs Garcìa; Nicola Giuliani; Paola Storti
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors

Exploration of Targeted Anti-tumor Therapy
2022-08-31 | Journal article
DOI: 10.37349/etat.2022.00095
Contributors: Vincenzo Raimondi; Nicolas Thomas Iannozzi; Jessica Burroughs-Garcìa; Denise Toscani; Paola Storti; Nicola Giuliani
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.684561
EID:

2-s2.0-85121937893

Part of ISSN: 2234943X
Contributors: Romano, A.; Storti, P.; Marchica, V.; Scandura, G.; Notarfranchi, L.; Craviotto, L.; Di Raimondo, F.; Giuliani, N.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients

Frontiers in Immunology
2021 | Journal article
DOI: 10.3389/fimmu.2020.613007
EID:

2-s2.0-85099407158

Part of ISSN: 16643224
Contributors: Costa, F.; Vescovini, R.; Marchica, V.; Storti, P.; Notarfranchi, L.; Dalla Palma, B.; Toscani, D.; Burroughs-Garcia, J.; Catarozzo, M.T.; Sammarelli, G. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets

Cells
2021-06-01 | Journal article
DOI: 10.3390/cells10061360
Contributors: Jessica Burroughs Garcìa; Rosa Alba Eufemiese; Paola Storti; Gabriella Sammarelli; Luisa Craviotto; Giannalisa Todaro; Denise Toscani; Valentina Marchica; Nicola Giuliani
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression

Cancers
2021-01-06 | Journal article
DOI: 10.3390/cancers13020164
Contributors: Federica Costa; Valentina Marchica; Paola Storti; Fabio Malavasi; Nicola Giuliani
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy

Journal of Hematology and Oncology
2020 | Journal article
DOI: 10.1186/s13045-020-00919-w
EID:

2-s2.0-85087883773

Part of ISSN: 17568722
Contributors: Marchica, V.; Franceschi, V.; Vescovini, R.; Storti, P.; Vicario, E.; Toscani, D.; Zorzoli, A.; Airoldi, I.; Dalla Palma, B.; Campanini, N. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

CD14<sup>+</sup>CD16<sup>+</sup> monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy

British Journal of Haematology
2020 | Journal article
DOI: 10.1111/bjh.16548
EID:

2-s2.0-85081285500

Part of ISSN: 13652141 00071048
Contributors: Storti, P.; Vescovini, R.; Costa, F.; Marchica, V.; Toscani, D.; Dalla Palma, B.; Craviotto, L.; Malavasi, F.; Giuliani, N.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability

Cancers
2020-11-05 | Journal article
DOI: 10.3390/cancers12113267
Contributors: Martina Chiu; Denise Toscani; Valentina Marchica; Giuseppe Taurino; Federica Costa; Massimiliano G. Bianchi; Roberta Andreoli; Valentina Franceschi; Paola Storti; Jessica Burroughs-Garcia et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies

Journal of Clinical Medicine
2020-09 | Journal article | Author
DOI: 10.3390/jcm9092864
Contributors: Paola Storti; Federica Costa; Valentina Marchica; Jessica Burroughs-Garcia; Benedetta dalla Palma; Denise Toscani; Rosa Alba Eufemiese; Nicola Giuliani
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma

Cancers
2020-05 | Journal article | Author
DOI: 10.3390/cancers12051332
Contributors: MARTINA MANZONI; Valentina Marchica; Paola Storti; Bachisio Ziccheddu; Gabriella Sammarelli; Giannalisa Todaro; Francesca Pelizzoni; Simone Salerio; Laura Notarfranchi; Alessandra Pompa et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Novel targets for the treatment of relapsing multiple myeloma

Expert Review of Hematology
2019 | Journal article
DOI: 10.1080/17474086.2019.1624158
EID:

2-s2.0-85068458803

Part of ISSN: 17474094 17474086
Contributors: Giuliani, N.; Accardi, F.; Marchica, V.; Dalla Palma, B.; Storti, P.; Toscani, D.; Vicario, E.; Malavasi, F.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

Cancers
2019-03 | Journal article | Author
DOI: 10.3390/cancers11030321
Contributors: Valentina Marchica; Denise Toscani; Anna Corcione; Marina Bolzoni; Paola Storti; Rosanna Vescovini; Elisa Ferretti; Benedetta Dalla Palma; Emanuela Vicario; Fabrizio Accardi et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

A retained transcriptomic profile characterizes CD138+ cells in the short time progression from smoldering to active multiple myeloma.

Haematologica
2019-03-07 | Journal article
DOI: 10.3324/haematol.2018.209999
PMID: 30846495
Source: Self-asserted source
Paola Storti
grade
Preferred source (of 2)‎

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts

Cancers
2019-02 | Journal article | Author
DOI: 10.3390/cancers11020261
Contributors: Joséphine Muller; Elodie Duray; Margaux Lejeune; Sophie Dubois; Erwan Plougonven; Angélique Léonard; Paola Storti; Nicola Giuliani; Martine Cohen-Solal; Ute Hempel et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Possible targets to treat myeloma-related osteoclastogenesis

Expert Review of Hematology
2018 | Journal article
DOI: 10.1080/17474086.2018.1447921
EID:

2-s2.0-85044533408
Contributors: Bolzoni, M.; Toscani, D.; Storti, P.; Marchica, V.; Costa, F.; Giuliani, N.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Neurofibromatosis type I and multiple myeloma coexistence: A possible link?

Hematology reports
2018-03 | Journal article
DOI: 10.4081/hr.2018.7457
PMID: 29721253
PMC: PMC5907645
Contributors: Accardi F; Marchica V; Mancini C; Maredi E; Racano C; Notarfranchi L; Martorana D; Storti P; Martella E; Palma BD et al.
Source: Self-asserted source
Paola Storti via Europe PubMed Central
grade
Preferred source (of 2)‎

Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

International Journal of Hematology
2017 | Journal article
DOI: 10.1007/s12185-016-2104-1
EID:

2-s2.0-84989882649
Contributors: Marchica, V.; Accardi, F.; Storti, P.; Mancini, C.; Martella, E.; Dalla Palma, B.; Bolzoni, M.; Todoerti, K.; Marcatti, M.; Schifano, C. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

IL21R expressing CD14<sup>+</sup>CD16<sup>+</sup> monocytes expand in multiple myeloma patients leading to increased osteoclasts

Haematologica
2017 | Journal article
DOI: 10.3324/haematol.2016.153841
EID:

2-s2.0-85017012877

Part of ISSN: 15928721 03906078
Contributors: Bolzoni, M.; Ronchetti, D.; Storti, P.; Donofrio, G.; Marchica, V.; Costa, F.; Agnelli, L.; Toscani, D.; Vescovini, R.; Todoerti, K. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

Cancer Cell
2017 | Journal article
DOI: 10.1016/j.ccell.2017.05.011
EID:

2-s2.0-85021380741
Contributors: Marchesini, M.; Ogoti, Y.; Fiorini, E.; Aktas Samur, A.; Nezi, L.; D'Anca, M.; Storti, P.; Samur, M.K.; Ganan-Gomez, I.; Fulciniti, M.T. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Role of Galectins in Multiple Myeloma.

International journal of molecular sciences
2017-12 | Journal article
DOI: 10.3390/ijms18122740
PMID: 29258207
Source: Self-asserted source
Paola Storti via Europe PubMed Central
grade
Preferred source (of 3)‎

Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.

British journal of haematology
2017-11 | Journal article
DOI: 10.1111/bjh.15026
PMID: 29143308
Source: Self-asserted source
Paola Storti via Europe PubMed Central
grade
Preferred source (of 2)‎

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties.

Oncotarget
2017-08 | Journal article
DOI: 10.18632/oncotarget.18085
PMID: 28881793
PMC: PMC5581092
Source: Self-asserted source
Paola Storti via Europe PubMed Central
grade
Preferred source (of 2)‎

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: A new attractive target

Blood
2016 | Journal article
DOI: 10.1182/blood-2016-01-690743
EID:

2-s2.0-84994667572
Contributors: Bolzoni, M.; Chiu, M.; Accardi, F.; Vescovini, R.; Airoldi, I.; Storti, P.; Todoerti, K.; Agnelli, L.; Missale, G.; Andreoli, R. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo

Leukemia
2016 | Journal article
DOI: 10.1038/leu.2016.137
EID:

2-s2.0-84975122307
Contributors: Storti, P.; Marchica, V.; Airoldi, I.; Donofrio, G.; Fiorini, E.; Ferri, V.; Guasco, D.; Todoerti, K.; Silbermann, R.; Anderson, J.L. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

Haematologica
2016 | Journal article
DOI: 10.3324/haematol.2015.133736
EID:

2-s2.0-84959289389
Contributors: Storti, P.; Toscani, D.; Airoldi, I.; Marchica, V.; Maiga, S.; Bolzoni, M.; Fiorini, E.; Campanini, N.; Martella, E.; Mancini, C. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome

Cancer Cell
2015 | Journal article
DOI: 10.1016/j.ccell.2015.04.007
EID:

2-s2.0-84929222950
Contributors: Colla, S.; Ong, D.S.T.; Ogoti, Y.; Marchesini, M.; Mistry, N.A.; Clise-Dwyer, K.; Ang, S.A.; Storti, P.; Viale, A.; Giuliani, N. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma

Leukemia
2014 | Journal article
DOI: 10.1038/leu.2013.385
EID:

2-s2.0-84898456500
Contributors: Silbermann, R.; Bolzoni, M.; Storti, P.; Guasco, D.; Bonomini, S.; Zhou, D.; Wu, J.; Anderson, J.L.; Windle, J.J.; Aversa, F. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: Effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells

Leukemia
2013 | Journal article
DOI: 10.1038/leu.2012.190
EID:

2-s2.0-84873567746
Contributors: Bolzoni, M.; Donofrio, G.; Storti, P.; Guasco, D.; Toscani, D.; Lazzaretti, M.; Bonomini, S.; Agnelli, L.; Capocefalo, A.; Dalla Palma, B. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Increased osteocyte death in multiple myeloma patients: Role in myeloma-induced osteoclast formation

Leukemia
2012 | Journal article
DOI: 10.1038/leu.2011.381
EID:

2-s2.0-84862003148
Contributors: Giuliani, N.; Ferretti, M.; Bolzoni, M.; Storti, P.; Lazzaretti, M.; Dalla Palma, B.; Bonomini, S.; Martella, E.; Agnelli, L.; Neri, A. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Angiogenesis and multiple myeloma

Cancer Microenvironment
2011 | Journal article
DOI: 10.1007/s12307-011-0072-9
EID:

2-s2.0-84856490243
Contributors: Giuliani, N.; Storti, P.; Bolzoni, M.; Palma, B.D.; Bonomini, S.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients

Leukemia
2011 | Journal article
DOI: 10.1038/leu.2010.270
EID:

2-s2.0-79952371298
Contributors: Storti, P.; Donofrio, G.; Colla, S.; Airoldi, I.; Bolzoni, M.; Agnelli, L.; Abeltino, M.; Todoerti, K.; Lazzaretti, M.; Mancini, C. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations

American Journal of Hematology
2011 | Journal article
DOI: 10.1002/ajh.22164
EID:

2-s2.0-81355127519
Contributors: Agnelli, L.; Storti, P.; Todoerti, K.; Sammarelli, G.; Dalla Palma, B.; Bolzoni, M.; Rocci, A.; Piazza, F.; Semenzato, G.; Palumbo, A. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide

Experimental Hematology
2011 | Journal article
DOI: 10.1016/j.exphem.2010.10.005
EID:

2-s2.0-78650209271
Contributors: Abeltino, M.; Bonomini, S.; Bolzoni, M.; Storti, P.; Colla, S.; Todoerti, K.; Agnelli, L.; Neri, A.; Rizzoli, V.; Giuliani, N.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients

Leukemia
2010 | Journal article
DOI: 10.1038/leu.2010.96
EID:

2-s2.0-77954659535
Contributors: Giuliani, N.; Lisignoli, G.; Novara, F.; Storti, P.; Zaffaroni, N.; Villa, R.; Sammarelli, G.; Agnelli, L.; Todoerti, K.; Bernardo, M.E. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease

Experimental Hematology
2010 | Journal article
DOI: 10.1016/j.exphem.2009.11.009
EID:

2-s2.0-74249093697
Contributors: Todoerti, K.; Lisignoli, G.; Storti, P.; Agnelli, L.; Novara, F.; Manferdini, C.; Codeluppi, K.; Colla, S.; Crugnola, M.; Abeltino, M. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma

Clinical Cancer Research
2010 | Journal article
DOI: 10.1158/1078-0432.CCR-10-0173
EID:

2-s2.0-77955720345
Contributors: Cocco, C.; Giuliani, N.; Di Carlo, E.; Ognio, E.; Storti, P.; Abeltino, M.; Sorrentino, C.; Ponzoni, M.; Ribatti, D.; Airoldi, I.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: Role on the transcriptional and proangiogenic profiles of CD138<sup>+</sup> cells

Leukemia
2010 | Journal article
DOI: 10.1038/leu.2010.193
EID:

2-s2.0-78149468597

Part of ISSN: 14765551 08876924
Contributors: Colla, S.; Storti, P.; Donofrio, G.; Todoerti, K.; Bolzoni, M.; Lazzaretti, M.; Abeltino, M.; Ippolito, L.; Neri, A.; Ribatti, D. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

CC-Chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions

Cancer Research
2008 | Journal article
DOI: 10.1158/0008-5472.CAN-08-0402
EID:

2-s2.0-53049088523
Contributors: Giuliani, N.; Lisignoli, G.; Colla, S.; Lazzaretti, M.; Storti, P.; Mancini, C.; Bonomini, S.; Manferdini, C.; Codeluppi, K.; Facchini, A. et al.
Source: Self-asserted source
Paola Storti via Scopus - Elsevier

Hypoxia-inducible factor (hif)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction.

Journal article
DOI: 10.1038/leu.2013.24
Source: Self-asserted source
Paola Storti
grade
Preferred source (of 2)‎

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

Journal article
DOI: 10.1016/j.exphem.2012.11.005
Source: Self-asserted source
Paola Storti
grade
Preferred source (of 2)‎
How many people are using ORCID?